TipRanks
National Healthcare Corp. (DE:HTW)
FRANKFURT:HTW
Germany Market
HTW
National Healthcare
RESEARCH TOOLSreports

National Healthcare (HTW) Ratios

0 Followers

National Healthcare Ratios

DE:HTW's free cash flow for Q2 2026 was $0.41. For the 2026 fiscal year, DE:HTW's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 22.06 1.77 1.81 1.89 1.79
Quick Ratio
 22.06 1.77 1.77 1.86 1.75
Cash Ratio
 2.79 0.44 0.32 0.50 0.30
Solvency Ratio
 0.45 0.36 0.27 0.27 0.16
Operating Cash Flow Ratio
 10.32 0.73 0.46 0.52 0.04
Short-Term Operating Cash Flow Coverage
 0.00 4.50 14.31 0.00 0.00
Net Current Asset Value
$ -5.30M$ -3.72M$ -116.86M$ 5.92M$ -44.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.06 0.14 0.07 0.10
Debt-to-Equity Ratio
 0.03 0.08 0.22 0.10 0.14
Debt-to-Capital Ratio
 0.03 0.08 0.18 0.09 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.03 0.12 0.00 0.00
Financial Leverage Ratio
 1.37 1.43 1.56 1.44 1.46
Debt Service Coverage Ratio
 74.83 3.66 12.74 332.24 108.40
Interest Coverage Ratio
 56.65 20.15 20.74 176.34 56.65
Debt to Market Cap
 0.00 0.03 0.08 0.00 0.00
Interest Debt Per Share
 2.17 6.04 14.22 6.12 8.21
Net Debt to EBITDA
 -0.08 -0.11 0.76 -0.10 0.99
Profitability Margins
Gross Profit Margin
39.49%39.31%37.52%37.60%36.13%
EBIT Margin
12.05%11.12%10.83%7.80%2.59%
EBITDA Margin
14.99%14.08%14.06%11.48%6.36%
Operating Profit Margin
9.28%8.46%6.61%5.00%2.97%
Pretax Profit Margin
11.89%10.70%10.51%7.77%2.53%
Net Profit Margin
9.00%7.91%7.85%5.85%2.09%
Continuous Operations Profit Margin
9.16%8.08%7.87%5.72%1.86%
Net Income Per EBT
75.67%73.89%74.72%75.28%82.42%
EBT Per EBIT
128.12%126.55%159.06%155.32%85.37%
Return on Assets (ROA)
9.13%7.86%6.69%5.10%1.76%
Return on Equity (ROE)
12.94%11.23%10.40%7.35%2.57%
Return on Capital Employed (ROCE)
9.53%10.08%6.65%5.21%2.96%
Return on Invested Capital (ROIC)
7.25%7.37%4.83%3.73%2.10%
Return on Tangible Assets
10.42%8.98%7.64%5.88%2.04%
Earnings Yield
4.04%5.66%6.16%4.72%2.45%
Efficiency Ratios
Receivables Turnover
 11.32 10.92 9.56 10.47 10.71
Payables Turnover
 43.40 40.46 31.81 37.11 40.46
Inventory Turnover
 0.00 0.00 89.71 96.45 96.81
Fixed Asset Turnover
 0.00 0.00 1.70 1.94 1.71
Asset Turnover
 1.01 0.99 0.85 0.87 0.84
Working Capital Turnover Ratio
 3.86 7.90 6.81 6.56 6.73
Cash Conversion Cycle
 23.83 24.41 30.79 28.82 28.82
Days of Sales Outstanding
 32.24 33.43 38.20 34.87 34.07
Days of Inventory Outstanding
 0.00 0.00 4.07 3.78 3.77
Days of Payables Outstanding
 8.41 9.02 11.47 9.83 9.02
Operating Cycle
 32.24 33.43 42.27 38.65 37.84
Cash Flow Ratios
Operating Cash Flow Per Share
 12.09 11.96 6.97 7.26 0.57
Free Cash Flow Per Share
 9.38 9.61 5.18 5.44 -1.39
CapEx Per Share
 2.71 2.36 1.79 1.82 1.96
Free Cash Flow to Operating Cash Flow
 0.78 0.80 0.74 0.75 -2.45
Dividend Paid and CapEx Coverage Ratio
 2.30 2.46 1.66 1.75 0.13
Capital Expenditure Coverage Ratio
 4.47 5.08 3.89 3.99 0.29
Operating Cash Flow Coverage Ratio
 6.01 2.13 0.50 1.19 0.07
Operating Cash Flow to Sales Ratio
 0.12 0.12 0.08 0.10 <0.01
Free Cash Flow Yield
4.22%7.01%4.81%5.89%-2.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.60 17.67 16.25 21.18 40.85
Price-to-Sales (P/S) Ratio
 2.23 1.40 1.28 1.24 0.85
Price-to-Book (P/B) Ratio
 3.09 1.98 1.69 1.56 1.05
Price-to-Free Cash Flow (P/FCF) Ratio
 23.68 14.27 20.77 16.98 -42.73
Price-to-Operating Cash Flow Ratio
 18.37 11.46 15.43 12.72 104.89
Price-to-Earnings Growth (PEG) Ratio
 0.75 1.03 0.31 0.11 -0.49
Price-to-Fair Value
 3.09 1.98 1.69 1.56 1.05
Enterprise Value Multiple
 14.77 9.81 9.83 10.69 14.41
Enterprise Value
 3.45B 2.10B 1.79B 1.40B 984.18M
EV to EBITDA
 14.77 9.81 9.83 10.69 14.41
EV to Sales
 2.21 1.38 1.38 1.23 0.92
EV to Free Cash Flow
 23.54 14.11 22.51 16.82 -45.87
EV to Operating Cash Flow
 18.27 11.33 16.72 12.60 112.58
Tangible Book Value Per Share
 60.01 57.15 51.50 48.02 45.57
Shareholders’ Equity Per Share
 71.86 69.08 63.67 59.36 56.73
Tax and Other Ratios
Effective Tax Rate
 0.23 0.25 0.25 0.26 0.27
Revenue Per Share
 99.82 98.10 84.32 74.56 69.71
Net Income Per Share
 8.98 7.76 6.62 4.36 1.46
Tax Burden
 0.76 0.74 0.75 0.75 0.82
Interest Burden
 0.99 0.96 0.97 1.00 0.98
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.03 0.03 0.03 0.04 0.04
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.32 1.51 1.05 1.70 0.44
Currency in USD